About Relation Therapeutics
Relation Therapeutics is a company based in London (United Kingdom) founded in 2020 by Benjamin Swerner. Relation Therapeutics has raised $116.43 million across 5 funding rounds from investors including Nvidia, Khosla Ventures and GSK. The company has 12 employees as of November 30, 2020. Relation Therapeutics offers products and services including Lab-in-the-Loop. Relation Therapeutics operates in a competitive market with competitors including DNAnexus, Cytel, Metagenomi, Ampersand and Octant, among others.
- Headquarter London, United Kingdom
- Employees 12 as on 30 Nov, 2020
- Founders Benjamin Swerner
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Relation Therapeutics Limited
- Date of Incorporation 08 Nov, 2019
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$116.43 M (USD)
in 5 rounds
-
Latest Funding Round
$36.18 M (USD), Seed
Nov 21, 2025
-
Investors
Nvidia
& 10 more
-
Employee Count
12
as on Nov 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Relation Therapeutics
Relation Therapeutics offers a comprehensive portfolio of products and services, including Lab-in-the-Loop.
Integrates single-cell analysis and machine learning for advancing medicines
People of Relation Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Relation Therapeutics
Relation Therapeutics has successfully raised a total of $116.43M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $36.18 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Relation Therapeutics
Relation Therapeutics has secured backing from 11 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Nvidia, Khosla Ventures and GSK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital firm focused on deep tech, fintech, and AI companies
|
Locked | Locked | Locked | |
|
Magnetic Ventures is focused on transforming healthcare through AI and biotech investments.
|
Locked | Locked | Locked |
Investor details for Relation Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Relation Therapeutics
Investment portfolio details for Relation Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Relation Therapeutics
Detailed financials for Relation Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Relation Therapeutics Comparisons
Peer comparison for Relation Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Relation Therapeutics
Relation Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Cytel, Metagenomi, Ampersand and Octant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| Locked | Locked | Locked |
Programmable medicines are developed to target and treat multiple diseases.
|
|
| Locked | Locked | Locked |
Human cell interaction platform is provided for drug discovery.
|
|
| Locked | Locked | Locked |
Bioinformatics platform for precision medicine development is offered.
|
Detailed competitors of Relation Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Relation Therapeutics
Complete news archive for Relation Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Relation Therapeutics
Relation Therapeutics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Relation Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
David Roblin is the current CEO of Relation Therapeutics.
Relation Therapeutics is a funded company, having raised a total of $116.43M across 5 funding rounds to date.
As of Nov 30, 2020, the latest employee count at Relation Therapeutics is 12.
Relation Therapeutics was founded in 2020 and is based in London, United Kingdom. Operations focus on the biotechnology sector, where software platforms for target and drug discovery are developed. Human genetics, single-cell omics, and perturbational data are leveraged by the platform to support genetic disease management. Tools are designed for use by researchers in advancing therapeutic development.
Relation Therapeutics's top competitors include DNAnexus, Cytel and Metagenomi.
Relation Therapeutics offers Lab-in-the-Loop.
Relation Therapeutics has 11 investors. Key investors include Nvidia, Khosla Ventures, GSK, ARK Investment Management, and DCVC.